This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 08/16/2021
Location: Virtual
Subject: Food Supply Chain Analytics and Sensing Initiative
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Retsef Levi, Stacy Springs (Massachusetts Institute of Technology);

Event Date: 08/18/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 08/18/2021
Location: Virtual
Subject: Listening Session with Coalition to Expand Contraception Access (CECA)
FDA Participant/Group: MEGAN HOWARD;
Non FDA Participant/Group: Stakeholders from the Coalition to Expand Contraception Access (CECA)

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/16/2021
Location: Virtual
Subject: Conference for Food Protection Biennial Meeting; Food Safety Success
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from food industry, academia, and government

Event Date: 08/20/2021
Location: Virtual
Subject: Annual Joint Food Safety Partnership Meeting with Mexico
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members from Mexico's National Service for Agrifood Health, Safety and Quality and several members of Federal Commission for the Protection Against Sanitary Risk

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 08/16/2021
Location: Virtual
Subject: Total Product Lifecyle Advisory Program
FDA Participant/Group: ELIZABETH HILLEBRENNER; SARA AGUEL; MALCOLM BERTONI; LAUREN ROTH; DOUGLAS KELLY;
Non FDA Participant/Group: Christopher White, Janet Trunzo, Scott Whitaker, Zach Rothstein (AdvaMed);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

Event Date: 08/17/2021
Location: Virtual
Subject: Product Jurisdiction Issues Concerning Anika Products
FDA Participant/Group: RAQUEL PEAT; ELIZABETH DICKINSON; THINH NGUYEN; LAURENCE COYNE; DAVID MEDNICK; ERIN KEEGAN; ANDREW YEATTS; JAMES BERTRAM; JAMES ALLRED; KRISTINA LAURITSEN; KENYA BROTHERS; SARAH MOLLO; LEIGH HAYES; CHERRYN CHANG; LAURA ROSE; JOSEPH MILONE; NAZIA RAHMAN; SIYEON LEE; AMANDA EDMONDS; ANDREW LEBOEUF;
Non FDA Participant/Group: David Fox, Heidi Gertner (Hogan Lovells); Carol Pekar, Cheryl Blanchard, David Colleran, Frank Luppino, Mira Leiwant (Anika Therapeutics);